Physician profile
Paul Azer
NPI 1336154707
$25,448.27
in general payments reported to CMS, 2019-2025
67 companies · $3,603 in 2025
The $3,603 reported for 2025 was more than what 97% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,007 · 2020: $1,941 · 2021: $3,464 · 2022: $4,307 · 2023: $4,407 · 2024: $4,720 · 2025: $3,603.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,729.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $2,608.64 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $2,549.17 | 2019-2025 | Jardiance, Synjardy, Tradjenta |
| Abbvie INC. | $1,735.71 | 2019-2025 | Ubrelvy, Synthroid |
| Insulet Corporation | $1,420.70 | 2019-2025 | Omnipod |
| Abbott Laboratories | $1,369.86 | 2019-2025 | Freestyle Libre 3 |
| Amgen INC. | $1,314.58 | 2019-2025 | Evenity, Prolia, Repatha |
| Corcept Therapeutics | $1,310.54 | 2020-2025 | Korlym |
| Mannkind Corporation | $1,310.52 | 2019-2025 | Afrezza |
| Novo Nordisk INC | $1,309.84 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Sanofi-Aventis U.S. LLC | $1,194.96 | 2019-2025 | |
| Astrazeneca Pharmaceuticals Lp | $736.76 | 2019-2023 | Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $714.45 | 2022-2025 | |
| Radius Health, INC. | $636.12 | 2019-2025 | Tymlos |
| Recordati_rare_diseases_inc. | $560.65 | 2022-2025 | Isturisa, Signifor Lar |
| Xeris Pharmaceuticals, INC. | $424.30 | 2021-2025 | Recorlev, Gvoke Hypopen |
Show all 67 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $422.73 | 2023-2024 | Dovato |
| Merck Sharp & Dohme LLC | $421.26 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $403.07 | 2022-2024 | |
| Horizon Therapeutics Plc | $314.32 | 2019-2023 | Tepezza |
| Currax Pharmaceuticals LLC | $312.45 | 2019-2024 | Contrave, Nexlizet, Nexletol |
| Janssen Pharmaceuticals, INC | $298.59 | 2019-2023 | Xarelto |
| Ibsa Pharma INC. | $295.90 | 2019-2023 | Tirosint, Licart |
| Tandem Diabetes Care, INC. | $285.87 | 2019-2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Alexion Pharmaceuticals, INC. | $255.67 | 2019-2025 | Strensiq |
| Dexcom, INC. | $241.24 | 2020-2025 | Dexcom G6 Transmitter |
| Medtronic, INC. | $237.92 | 2021-2024 | Minimed 780g, Accurian |
| Madrigal Pharmaceuticals | $224.55 | 2025 | Rezdiffra |
| Becton, Dickinson and Company | $221.64 | 2021-2022 | |
| Ascensia Diabetes Care US INC. | $159.73 | 2023-2025 | |
| Medtronic Vascular, INC. | $145.88 | 2019 | |
| Kyowa Kirin, INC. | $134.85 | 2023-2025 | Crysvita |
| Embecta Corp. | $127.71 | 2023 | Bd Nano 2nd Gen Pen Needle |
| Alvogen INC | $122.59 | 2023-2025 | Teriparatide |
| Endo Pharmaceuticals INC. | $118.95 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $117.49 | 2022-2025 | Evkeeza |
| Lifescan, INC. | $105.78 | 2019-2022 | |
| Alfasigma USA, INC. | $84.98 | 2021-2022 | |
| Lexicon Pharmaceuticals, INC. | $74.35 | 2023-2024 | Inpefa |
| Ipsen Biopharmaceuticals, INC | $73.46 | 2019-2021 | |
| Zealand Pharma US, INC. | $71.33 | 2020-2021 | |
| Antares Pharma, INC. | $70.68 | 2023 | Nocdurna, Xyosted, Tlando |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $68.11 | 2022-2024 | Xifaxan |
| Neurocrine Biosciences, INC. | $62.03 | 2025 | |
| Eusa Pharma (US) LLC | $61.04 | 2022 | |
| Grt US Holding, INC. | $60.56 | 2021-2022 | |
| Esperion Therapeutics, INC. | $57.53 | 2021-2025 | Nexletol |
| Halozyme INC | $48.11 | 2023 | |
| Shire North American Group INC | $47.94 | 2019 | |
| Eisai INC. | $46.40 | 2019-2021 | |
| Intra-Sana Laboratories | $39.01 | 2024-2025 | Reltone 400 Mg, Glycate, Reltone 200 Mg |
| Amneal Pharmaceuticals LLC | $35.57 | 2019 | |
| Tolmar, INC. | $34.92 | 2024 | |
| Acella Pharmaceuticals, LLC | $29.86 | 2024 | NP Thyroid 60 |
| Cequr Corporation | $29.06 | 2023 | Cequr Simplicity |
| Biohaven Pharmaceutical Holding Company Ltd. | $27.17 | 2022 | |
| Medtronic Minimed, INC. | $26.81 | 2019 | |
| Bigfoot Biomedical INC | $26.35 | 2022 | |
| Sequel Med Tech, LLC | $24.98 | 2025 | Twiist |
| Exact Sciences Corporation | $23.83 | 2023 | Cologuard Collection Kit |
| Vivus LLC | $22.89 | 2023 | Qsymia |
| Amryt Pharma Holdings Ltd | $22.69 | 2023 | Mycapssa |
| Genzyme Corporation | $19.86 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $19.26 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $19.01 | 2021 | |
| Nalpropion Pharmaceuticals LLC | $19.00 | 2019 | |
| Acerus Pharmaceuticals Corporation | $18.55 | 2020 | |
| Arbor Pharmaceuticals, INC. | $17.94 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Azer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.